Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1

8 Mar 2017

Abstract excerpt

•Genomic alterations may improve diagnostic certainty and subsequent treatment of endometrial stromal sarcoma.•Novel JAZF1-BCORL1 mutation was identified.•Targeted therapeutics to down-stream targets may improve survival benefit in these patients.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ovarian cancer diagnosis and treatment
Share to Sarcoma Diagnosis and Treatment
Share to Uterine Myomas and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28331900
DOI: 10.1016/j.gore.2017.03.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1PMID 28331900Read ↗

Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas.Semantic proximity Read ↗

Novel EPC1 gene fusions in endometrial stromal sarcomaSemantic proximity Read ↗

Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural HistorySemantic proximity Read ↗

Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genome profilingSemantic proximity Read ↗

Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 AmplificationsSemantic proximity Read ↗

Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment ChangesSemantic proximity Read ↗

Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal SarcomaSemantic proximity Read ↗

Endometrial stromal sarcoma – the new genetic paradigmSemantic proximity Read ↗

Targeted RNA Sequencing Highlights a Diverse Genomic and Morphologic Landscape in Low-grade Endometrial Stromal Sarcoma, Including Novel Fusion GenesSemantic proximity Read ↗

Molecular Classification and Emerging Targeted Therapy in Endometrial CancerSemantic proximity Read ↗

Endometrial stromal tumors: the new WHO classification.Semantic proximity Read ↗

CTNNB1 mutation represents a recurrent driver molecular alteration in a subset of endometrial stromal tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.